Cancer Research UK’s latest phase of the ACE (Accelerate, Coordinate, Evaluate) Programme is focused on reducing unwarranted variation in accessing optimal standards of diagnostics and treatment for patients diagnosed with lung cancer.
The programme is being clinically led by Professor Mick Peake and there are several strands to the work including, exploring the defined assessment protocols and associated treatment options for those patients that present as complex or high-risk (also often described as borderline fit) for radical therapies.
ACE is particularly interested to hear the views of the thoracic surgical community, on how this complex patient is considered eligible for radical treatment, including patient fitness assessment.
Please share your views in this short on-line survey here which has been endorsed by Doug West and Steve Woolley from the SCTS. It should only take a few minutes to complete.